Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC1 | P07992 | 2/20 | 0.52 |
| ▸ | FEN1 | P39748 | 2/20 | 0.52 |
| ▸ | ERCC4 | Q92889 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30643813 | 0.78 | MAOA (0.54) | ERCC1FEN1ERCC4CA1CA2 | |
| SCHEMBL43760 | 0.78 | PABPC1 (0.55) | ERCC1FEN1ERCC4POLBMAPT | |
| SCHEMBL9279014 | 0.78 | DDB1 (0.44) | CA1CA2CA7CA9DDB1 | |
| SCHEMBL3211320 | 0.78 | MAOA (0.54) | ERCC1FEN1ERCC4CA1CA2 | |
| SCHEMBL4407778 | 0.76 | MAPT (0.56) | ERCC1FEN1ERCC4POLBMAPT | |
| SCHEMBL6656873 | 0.76 | FEN1 (0.52) | ERCC1FEN1ERCC4CA1CA2 | |
| SCHEMBL9853619 | 0.76 | ERCC1 (0.38) | ERCC1FEN1ERCC4POLBMAPT | |
| SCHEMBL3220477 | 0.76 | ERCC1 (0.52) | ERCC1FEN1ERCC4CA1CA2 | |
| SCHEMBL31405120 | 0.76 | MAPT (0.56) | ERCC1FEN1ERCC4POLBMAPT | |
| SCHEMBL30725964 | 0.76 | MEN1 (0.53) | CA1CA2CA7CA9POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0417445-A1 | Single pot process for making a fluoroanthranilic acid | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-03-20 | — | — | EP | claimed |
| US-4954639-A | REACTING FLUOROPHTHALIC ACID COMPOUND WITH HYDROXYLAMINE OR SALT | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-09-04 | — | — | US | claimed |
| US-20230142883-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
| US-11560381-B1 | Compounds and uses thereof | FOGHORN THERAPEUTICS INC. (US) | 2023-01-24 | — | — | US | disclosed |
| EP-0417445-A1 | Single pot process for making a fluoroanthranilic acid | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-03-20 | — | — | EP | disclosed |
| EP-0417445-A1 | Single pot process for making a fluoroanthranilic acid | OCCIDENTAL CHEMICAL CORPORATION (US) | 1991-03-20 | — | — | EP | disclosed |
| US-4954639-A | REACTING FLUOROPHTHALIC ACID COMPOUND WITH HYDROXYLAMINE OR SALT | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-09-04 | — | — | US | disclosed |
| US-4954639-A | REACTING FLUOROPHTHALIC ACID COMPOUND WITH HYDROXYLAMINE OR SALT | OCCIDENTAL CHEMICAL CORPORATION (US) | 1990-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142883-A1 | COMPOUNDS AND USES THEREOF | VHL, TFEB, BECN1 | ERCC1 198/4885FEN1 2174/4885ERCC4 90/4885 |
| US-11560381-B1 | Compounds and uses thereof | VHL, TFEB, BECN1 | ERCC1 198/4885FEN1 2174/4885ERCC4 90/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.